StockNews.com Begins Coverage on China Pharma (NYSE:CPHI)

StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research note published on Sunday. The brokerage issued a hold rating on the stock.

China Pharma Price Performance

NYSE CPHI opened at $0.31 on Friday. The company has a quick ratio of 0.33, a current ratio of 0.88 and a debt-to-equity ratio of 0.19. China Pharma has a 52 week low of $0.27 and a 52 week high of $2.70. The firm’s 50-day simple moving average is $0.36 and its two-hundred day simple moving average is $0.46.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.